LS CancerDiag strengthens the management team in 2019

LS CancerDiag strengthens the management team in 2019

The last year of this decade has been a very successful one for LS CancerDiag, where many important milestones were achieved, and the basis was laid for strong growth over the coming years. To gear up for a promising 2020, LS CancerDiag has strengthened its management team to take the next step towards its ambitious vision to make DiagMMR® the Gold standard for Lynch syndrome detection.

Click below to read the full press release:

LSCD_Press_Release_2019_CxO

LS CancerDiag Press Release

LS CancerDiag strengthens the management team in 2019

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.